Search results
US Senator Sanders optimistic Novo Nordisk can be pressured to cut Wegovy, Ozempic prices - ETPharma
The Economic Times· 3 days agoWashington: Senator Bernie Sanders on Wednesday expressed confidence that Novo Nordisk can be...
Novo Nordisk faces scrutiny on Capitol Hill for pulling Levemir insulin from US market - ET...
The Economic Times· 1 day agoLondon: Democratic U.S. Senate aides will meet with Novo Nordisk executives on Tuesday to discuss fallout from its decision to stop selling one of its long-acting ...
Novo Nordisk, Indonesia's Bio Farma set to make insulin - ET HealthWorld | Pharma
The Economic Times· 4 days agoJakarta: Danish drugmaker Novo Nordisk has signed a deal with Indonesia's state-owned pharmaceutical...
Novo Nordisk applies for more reimbursements for Wegovy in Norway - ET HealthWorld | Pharma
The Economic Times· 2 days agoCopenhagen: Danish drugmaker Novo Nordisk said on Thursday it had applied to the Norwegian health...
After AdCom rejection, FDA rebuffs Novo Nordisk’s once-weekly insulin
Pharmaceutical Technology· 3 days agoThe US Food and Drug Administration (FDA) has rejected the biologics licence application (BLA) for ...
UK pharma group reprimands Novo Nordisk for undisclosed payments
Pharmaceutical Technology· 6 days agoThe Association of the British Pharmaceutical Industry (ABPI) has pulled up four pharmaceutical...
Novo Nordisk shares down after analysis finds Lilly drug leads to better weight loss - ET...
The Economic Times· 5 days agoLondon: Shares in Novo Nordisk , maker of the wildly popular obesity drug Wegovy, were down 1.1 per...
Ozempic linked with lower dementia risk, nicotine use, British study finds - ET HealthWorld | Pharma
The Economic Times· 1 day agoLondon: Novo Nordisk's popular diabetes treatment Ozempic could be tied to a lower risk of cognitive...
Antidiabetic drug Semaglutide linked to potential vision loss: Study
Business Standard India· 6 hours agoThe drug is sold under the brand names Wegovy, Rybelsus, and Ozempic by Danish drug major Novo ...
Pfizer along witth Eli Lilly and Novo Nordisk, enroute to develop their second generation weight...
CNBC TV18· 3 days agoPfizer plans to move a reworked, once-a-day version of its weight loss pill, danuglipron, into...